STAT3 and neoplasm: IL-6 also promotes MDSC accumulation and inhibits anti-tumor immunity by activating the JAK/STAT3 signaling pathway, which results in increased production of ROS, NO, and PD-L1 (Ostrand-Rosenberg and Fenselau, 1950; Weber et al., 2021).